Zolpidem arousing effect in persistent vegetative state patients: Autonomic, EEG and behavioral assessment

Current Pharmaceutical Design

Volumn 20, Issue 26, 2014, Pages 4185-4202

  Machado, Calixto ^a   Estévez, Mario ^a   Rodríguez, Rafael ^b   Pérez Nellar, Jesús ^c   Chinchilla, Mauricio ⁱ   DeFina, Philip ^d   Leisman, Gerry ^e   Carrick, Frederick R ^f   Melillo, Robert ^e   Schiavi, Adam ^g   Gutiérrez, Joel ^a   Carballo, Maylén ^b   Machado, Andrés ^h   Olivares, Ana ^a   Pérez Cruz, Nuvia ^a  

^a INSTITUTO DE NEUROLOGÍA Y NEUROCIRUGÍA   (Cuba)

^b CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

^c HOSPITAL CLINICOQUIRÚRGICO HERMANOS AMEIJEIRAS   (Cuba)

^d International Brain Research Foundation   (United States)

^e FR Carrick Research Institute Israel   (Israel)

^f FR Carrick Institute for Graduate Studies   (United States)

^g DEPARTMENT OF PATHOLOGY   (United States)

^h UNIVERSITY OF HAVANA   (Cuba)

ⁱ NONE

Author keywords

Arousal; Autonomic; EEG; Heart rate variability; Persistent vegetative state; Zolpidem

Indexed keywords

PLACEBO; ZOLPIDEM; PYRIDINE DERIVATIVE;

ADOLESCENT; ADULT; AROUSAL; AUTONOMIC NERVOUS SYSTEM FUNCTION; BRAIN FUNCTION; CHRONOTROPISM; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; ELECTROENCEPHALOGRAM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEART RATE VARIABILITY; HEMODYNAMIC PARAMETERS; HICCUP; HUMAN; MALE; PERSISTENT VEGETATIVE STATE; PHYSIOLOGIC MONITORING; PLACEBO EFFECT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SPECTROSCOPY; SYMPATHETIC TONE; THERAPY EFFECT; YAWNING; AUTONOMIC NERVOUS SYSTEM; DRUG EFFECTS; ELECTROENCEPHALOGRAPHY; HEART RATE; MIDDLE AGED; PATHOPHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AUTONOMIC NERVOUS SYSTEM; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PERSISTENT VEGETATIVE STATE; PYRIDINES; YOUNG ADULT;

EID: 84904728023     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: None     Document Type: Review

References (152)

1. Clauss RP, van der Merwe CE, Nel HW. Arousal from a semicomatose state on zolpidem. S Afr Med J 2001; 91(10): 788-9.
2. Clauss RP, Guldenpfennig WM, Nel HW, Sathekge MM, Venkannagari RR. Extraordinary arousal from semi-comatose state on zolpidem. A case report. S Afr Med J 2000; 90 (1): 68-72.
3. Cohen SI, Duong TT. Increased arousal in a patient with anoxic brain injury after administration of zolpidem. Am J Phys Med Rehabil 2008; 87 (3): 229-31.
4. Singh R, McDonald C, Dawson K, et al. Zolpidem in a minimally conscious state. Brain Inj 2008; 22 (1): 103-6.
5. Whyte J, Myers R. Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: a preliminary placebo controlled trial. Am J Phys Med Rehabil 2009; 88(5): 410-8.
6. Dang A, Garg A, Rataboli PV. Role of Zolpidem in the Management of Insomnia. CNS Neurosci Ther 2010.
7. Clauss R, Nel W. Drug induced arousal from the permanent vegetative state. NeuroRehabilitation 2006; 21 (1): 23-8.
8. Brefel-Courbon C, Payoux P, Ory F, et al. Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy. Ann Neurol 2007; 62(1): 102-5.
9. Du B, Yang D, Shan A, Xiang W. Neural regeneration research Volume: 3 Issue: 1 Pages: 94-96 Published: 2008 ed.; 2008; 1673-4.
10. Shames JL, Ring H. Transient reversal of anoxic brain injuryrelated minimally conscious state after zolpidem administration: a case report. Arch Phys Med Rehabil 2008; 89(2): 386-8.
11. Clauss RP, Nel WH. Effect of zolpidem on brain injury and diaschisis as detected by 99mTc HMPAO brain SPECT in humans. Arzneimittelforschung 2004; 54(10): 641-6.
12. Snyman N, Egan JR, London K, et al. Zolpidem for persistent vegetative state--a placebo-controlled trial in pediatrics. Neuropediatrics 2010; 41(5): 223-7.
13. Yang W, Dollear M, Muthukrishnan SR. One rare side effect of zolpidem--sleepwalking: a case report. Arch Phys Med Rehabil 2005; 86(6): 1265-6.
14. Rodriguez-Rojas R, Machado C, Alvarez L, et al. Zolpidem induces paradoxical metabolic and vascular changes in a patient with PVS. Brain Inj. 2013; 27(11):1320-9.
15. Clauss RP, Nel WH. Effect of zolpidem on brain injury and diaschisis as detected by 99mTc HMPAO brain SPECT in humans. Arzneimittelforschung 2004; 54(10): 641-6.
16. Cohen SI, Duong TT. Increased arousal in a patient with anoxic brain injury after administration of zolpidem. Am J Phys Med Rehabil 2008; 87(3): 229-31.
17. Giacino JT, Malone R. The vegetative and minimally conscious states. Handb Clin Neurol 2008; 90: 99-111.
18. Giacino JT. The vegetative and minimally conscious states: consensus-based criteria for establishing diagnosis and prognosis. Neuro Rehabil 2004; 19(4): 293-8.
19. Giacino JT, Kalmar K, Whyte J. The JFK Coma Recovery ScaleRevised: measurement characteristics and diagnostic utility. Arch Phys Med Rehabil 2004; 85(12): 2020-9.
20. Kalmar K, Giacino JT. The JFK Coma Recovery Scale--Revised. Neuropsychol Rehabil 2005; 15(3-4): 454-60.
21. Montes-Brown J, Machado A, Estevez M, Carricarte C, VelazquezPerez L. Autonomic dysfunction in presymptomatic spinocerebellar ataxia type-2. Acta Neurol Scand 2012; 125(1): 24-9.
22. Carricarte C, Montes Brown J, Rodríguez M, Machado C, Estévez M. Multiple Regression Analysis Applied to Heart Rate Variability Studies: A Methodological Approach. Funct Neurol Rehabil Ergon 2012; 2(1):46-7.
23. Montes-Brown J, Machado A, Estévez M, Carricarte C, VelazquezPerez L. DOI 10.1111/j.1600-0404.2011.01494.x. ed.; 2011.
24. Montes-Brown J, Sanchez-Cruz G, Garcia AM, Baez ME, Velazquez-Perez L. 122 ed.; 2010.
25. Zefferino R, L'Abbate N, Facciorusso A, et al. [Assessment of heart rate variability (HRV) as a stress index in an emergency team Am J Physiol Heart Circ Physiol 2009; 296(5): H1651-9.
26. Blain G, Meste O, Blain A, Bermon S. Time-frequency analysis of heart rate variability reveals cardiolocomotor coupling during dynamic cycling exercise in humans. Ital Med Lav Ergon 2003; 25 Suppl(3): 167-9.
27. Peters CH, Vullings R, Rooijakkers MJ, Bergmans JW, Oei SG, Wijn PF. A continuous wavelet transform-based method for timefrequency analysis of artifactcorrected heart rate variability data. Physiol Meas 2011; 32(10): 1517-27.
28. Martinmäki K, Rusko H. Time-frequency analysis of heart rate variability during immediate recovery from low and high intensity exercise. Eur J Appl Physiol 2008; 102(3): 353-60.
29. Martinmäki K, Rusko H, Saalasti S, Kettunen J. Ability of shorttime Fourier transform method to detect transient changes in vagal effects on hearts: a pharmacological blocking study. Am J Physiol Heart Circ Physiol 2006; 290(6): H2582-9.
30. Chan HL, Huang HH, Lin JL. Time-Frequency analysis of heart rate variability during transient segments. Ann Biomed Eng 2001; 29(11): 983-96.
31. Elsenbruch S, Wang Z, Orr WC, Chen JD. Time-frequency analysis of heart rate variability using short-time fourier analysis. Physiol Meas 2000; 21(2): 229-40.
32. Wen F, He FT. An efficient method of addressing ectopic beats: new insight into data preprocessing of heart rate variability analysis. J Zhejiang Univ Sci B 2011; 12(12): 976-82.
33. Thong T, Yung IO, P'Zajdel DP, et al. Heart rate variability analysis of effect of nicotine using periodograms. Conf Proc IEEE Eng Med Biol Soc 2004; 1: 294-7.
34. Berntson GG, Bigger JT Jr, Eckberg DL, et al. Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology 1997; 34(6): 623-48.
35. Clauss R, Sathekge M, Nel W. Transient improvement of spinocerebellar ataxia with zolpidem. N Engl J Med 2004; 351(5): 511-2.
36. Clauss R, Nel W. Drug induced arousal from the permanent vegetative state. Neuro Rehabil 2006; 21(1): 23-8.
37. Clauss RP. Neurotransmitters in coma, vegetative and minimally conscious states, pharmacological interventions. Med Hypotheses 2010; 75(3):287-90.
38. Clauss RP, Dormehl IC, Kilian E, Louw WK, Nel WH, Oliver DW. Cerebral blood perfusion after treatment with zolpidem and flumazenil in the baboon. Arzneimittelforschung 2002; 52(10): 740-4.
39. Clauss RP, Dormehl IC, Oliver DW, Nel WH, Kilian E, Louw WK. Measurement of cerebral perfusion after zolpidem administration in the baboon model. Arzneimittelforschung 2001; 51(8): 619-22.
40. Clauss RP. Neurotransmitters in disorders of consciousness and brain damage. Med Hypotheses 2011; 77(2): 209-13.
41. Oliveira L, Fregni F. Pharmacological and electrical stimulation in chronic disorders of consciousness: new insights and future directions. Brain Inj 2011; 25(4): 315-27.
42. Georgiopoulos M, Katsakiori P, Kefalopoulou Z, Ellul J, Chroni E, Constantoyannis C. Vegetative state and minimally conscious state: a review of the therapeutic interventions. Stereotact Funct Neurosurg 2010; 88(4): 199-207.
43. Shah SA, Schiff ND. Central thalamic deep brain stimulation for cognitive neuromodulation-a review of proposed mechanisms and investigational studies. Eur J Neurosci 2010; 32(7): 1135-44.
44. Goldfine AM, Schiff ND. Consciousness: its neurobiology and the major classes of impairment. Neurol Clin 2011; 29(4): 723-37.
45. Goldfine AM, Schiff ND. What is the role of brain mechanisms underlying arousal in recovery of motor function after structural brain injuries? Curr Opin Neurol 2011; 24(6): 564-9.
46. Laureys S, Schiff ND. Coma and consciousness: paradigms (re)framed by neuroimaging. Neuroimage 2012; 61(2): 478-91.
47. Rodriguez MD, Schiff ND, Giacino J, Kalmar K, Hirsch J. A network approach to assessing cognition in disorders of consciousness. Neurology 2010; 75(21): 1871-8.
48. Rodriguez MD, Schiff ND, Giacino J, Kalmar K, Hirsch J. A network approach to assessing cognition in disorders of consciousness. Neurology 2010; 75(21): 1871-8.
49. Schiff ND. Moving toward a generalizable application of central thalamic deep brain stimulation for support of forebrain arousal regulation in the severely injured brain. Ann N Y Acad Sci 2012; 1265: 56-68.
50. Schiff ND. Central thalamic deep brain stimulation for support of forebrain arousal regulation in the minimally conscious state. Handb Clin Neurol 2013; 116: 295-306.
51. Broussard DL, Li H, Altschuler SM. Colocalization of GABA(A) and NMDA receptors within the dorsal motor nucleus of the vagus nerve (DMV) of the rat. Brain Res 1997; 763(1): 123-6.
52. Cortes-Romero C, Galindo F, Galicia-Isasmendi S, Flores A. GABA: a functional duality? Transition during neurodevelopment. Rev Neurol. 2011;52(11):665-75.
53. Rae C, Nasrallah FA, Griffin JL, Balcar VJ. Now I know my ABC. A systems neurochemistry and functional metabolomic approach to understanding the GABAergic system. J Neurochem 2009; 109 (Suppl 1): 109-16.
54. Nasrallah FA, Griffin JL, Balcar VJ, Rae C. Understanding your inhibitions: modulation of brain cortical metabolism by GABA(B) receptors. J Cereb Blood Flow Metab 2007; 27(8): 1510-20.
55. Farrant M, Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci 2005; 6(3): 215-29.
56. Lee S, Yoon BE, Berglund K, et al. Channel-mediated tonic GABA release from glia. Science 2010; 330(6005): 790-6.
57. Wang L, Spary E, Deuchars J, Deuchars SA. 28 ed.; 2008.
58. Gao H, Smith BN. Zolpidem modulation of phasic and tonic GABA currents in the rat dorsal motor nucleus of the vagus. Neuropharmacology 2010; 58(8): 1220-7.
59. Chen L, Savio Chan C, Yung WH. Electrophysiological and behavioral effects of zolpidem in rat globus pallidus. Exp Neurol 2004; 186(2): 212-20.
60. Goetz T, Arslan A, Wisden W, Wulff P. GABA(A) receptors: structure and function in the basal ganglia. Prog Brain Res 2007; 160: 21-41.
61. Möhler H. GABA(A) receptor diversity and pharmacology. Cell Tissue Res 2006; 326(2): 505-16.
62. Duncan GE, Breese GR, Criswell HE, et al. Distribution of [3H]zolpidem binding sites in relation to messenger RNA encoding the alpha 1, beta 2 and gamma 2 subunits of GABAA receptors in rat brain. Neuroscience 1995; 64(4): 1113-28.
63. Auta J, Impagnatiello F, Kadriu B, Guidotti A, Costa E. Imidazenil: a low efficacy agonist at alpha1-but high efficacy at alpha5-GABAA receptors fail to show anticonvulsant cross tolerance to diazepam or zolpidem. Neuropharmacology 2008; 55(2): 148-53.
64. Nuwer MR, Hovda DA, Schrader LM, Vespa PM. Routine and quantitative EEG in mild traumatic brain injury. Clin Neurophysiol 2005; 116(9): 2001-25.
65. Tecchio F, Zappasodi F, Tombini M, et al. Brain plasticity in recovery from stroke: an MEG assessment. Neuroimage 2006; 32(3): 1326-34.
66. Escudero J, Hornero R, Abasolo D, Fernandez A, Poza J. Magnetoencephalogram blind source separation and component selection procedure to improve the diagnosis of Alzheimer's disease patients. Conf Proc IEEE Eng Med Biol Soc 2007; 2007: 5437-40.
67. Poza J, Hornero R, Abasolo D, Fernandez A, Escudero J. Analysis of spontaneous MEG activity in patients with Alzheimer's disease using spectral entropies. Conf Proc IEEE Eng Med Biol Soc 2007; 2007: 6180-3.
68. Canive JM, Lewine JD, Edgar JC, et al. Magnetoencephalographic assessment of spontaneous brain activity in schizophrenia. Psychopharmacol Bull 1996; 32(4): 741-50.
69. Hall SD, Yamawaki N, Fisher AE, Clauss RP, Woodhall GL, Stanford IM. GABA(A) alpha-1 subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke--a case report. Clin Neurophysiol 2010; 121(4): 549-55.
70. Clauss RP. Neurotransmitters in disorders of consciousness and brain damage. Med Hypotheses 2011.
71. RP Clauss. doi:10.1016/j.mehy.2010.03.005 ed.; 2010.
72. Tomita Y, Matsumura K, Wakamatsu Y, et al. Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart. J Cell Biol 2005; 170(7): 1135-46.
73. Pistoia F, Mura E, Govoni S, Fini M, Sara M. Awakenings and awareness recovery in disorders of consciousness: is there a role for drugs? CNS Drugs 2010; 24(8): 625-38.
74. Hawkins RA, O'Kane RL, Simpson IA, Vina JR. Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr 2006; 136(1 Suppl): 218S-26.
75. Hawkins RA. The blood-brain barrier and glutamate. Am J Clin Nutr 2009; 90(3): 867S-74.
76. Nyakale NE, Clauss RP, Nel W, Sathekge M. Clinical and brain SPECT scan response to zolpidem in patients after brain damage. Arzneimittelforschung 2010; 60(4): 177-81.
77. Nabekura J, Ueno T, Okabe A, et al. Reduction of KCC2 expression and GABAA receptor-mediated excitation after in vivo axonal injury. J Neurosci 2002; 22(11): 4412-7.
78. Ueno T, Okabe A, Akaike N, Fukuda A, Nabekura J. Diversity of neuron-specific K+-Cl-cotransporter expression and inhibitory postsynaptic potential depression in rat motoneurons. J Biol Chem 2002; 277(7): 4945-50.
79. Alvarez M, Guell R, Daniel L, Berazain AR, Machado C, Pascual A. Neuro-cognitive condition of 8 year old children with congenital hypothyroidism treated early. Rev Neurol 1999; 28(7): 701-6.
80. Machado C. Cerebral processing in the minimally conscious state. Neurology 2005; 65(6): 973-4.
81. Machado C. Can vegetative state patients retain cortical processing? Clin Neurophysiol 2005; 116(10): 2253-4.
82. Brain Death: A reappraisal New York, Springer, 2007; 121-6.
83. Machado C, Estevez M, Perez-Nellar J, et al. Autonomic, EEG, and behavioral arousal signs in a PVS case after Zolpidem intake. Can J Neurol Sci 2011; 38(2): 341-4.
84. Machado C. The minimally conscious state: definition and diagnostic criteria. Neurology 2002; 59(9): 1473-4.
85. Vanini G, Torterolo P, McGregor R, Chase MH, Morales FR. GABAergic processes in the mesencephalic tegmentum modulate the occurrence of active (rapid eye movement) sleep in guinea pigs. Neuroscience 2007; 145(3): 1157-67.
86. Hodelin-Tablada R, Machado C. [On the subject of sleep and waking]. Rev Neurol 2010; 51(12): 766-7.
87. Torterolo P, Vanini G. [New concepts in relation to generating and maintaining arousal]. Rev Neurol 2010; 50(12): 747-58.
88. Askenasy JJ. Is yawning an arousal defense reflex? J Psychol 1989; 123(6): 609-21.
89. Lin JS, Anaclet C, Sergeeva OA, Haas HL. The waking brain: an update. Cell Mol Life Sci 2011; 68(15): 2499-512.
90. Lapierre JL, Kosenko PO, Kodama T, et al. Symmetrical serotonin release during asymmetrical slow-wave sleep: implications for the neurochemistry of sleep-waking states. J Neurosci 2013; 33(6): 2555-61.
91. Kheiri F, Bragin A, Jr JE. Functional connectivity between brain areas estimated by analysis of gamma waves. J Neurosci Methods 2013; 214(2): 184-91.
92. Fuller PM, Sherman D, Pedersen NP, Saper CB, Lu J. Reassessment of the structural basis of the ascending arousal system. J Comp Neurol 2011; 519(5): 933-56.
93. Haas HL, Lin JS. Waking with the hypothalamus. Pflugers Arch 2012; 463(1): 31-42.
94. Portas CM, Rees G, Howseman AM, Josephs O, Turner R, Frith CD. A specific role for the thalamus in mediating the interaction of attention and arousal in humans. J Neurosci 1998; 18(21): 8979-89.
95. Denoyer M, Sallanon M, Buda C, Kitahama K, Jouvet M. Neurotoxic lesion of the mesencephalic reticular formation and/or the posterior hypothalamus does not alter waking in the cat. Brain Res 1991; 539(2): 287-303.
96. Steriade M. Brain activation, then (1949) and now: coherent fast rhythms in corticothalamic networks. Arch Ital Biol 1995; 134(1): 5-20.
97. Steriade M, Amzica F. Intracortical and corticothalamic coherency of fast spontaneous oscillations. Proc Natl Acad Sci USA 1996; 93(6): 2533-8.
98. Schiff ND. Recovery of consciousness after brain injury: a mesocircuit hypothesis. Trends Neurosci 2010; 33(1): 1-9.
99. Schiff ND, Posner JB. Another "Awakenings". Ann Neurol 2007; 62(1): 5-7.
100. Semba K. The cholinergic basal forebrain: a critical role in cortical arousal. Adv Exp Med Biol 1991; 295: 197-218.
101. Szymusiak R. Magnocellular nuclei of the basal forebrain: substrates of sleep and arousal regulation. Sleep 1995; 18(6): 478-500.
102. Sarter M, Bruno JP, Turchi J. Basal forebrain afferent projections modulating cortical acetylcholine, attention, and implications for neuropsychiatric disorders. Ann N Y Acad Sci 1999; 877: 368-82.
103. Sarter M, Bruno JP. Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents. Neuroscience 2000; 95(4): 933-52.
104. Espana RA, Reis KM, Valentino RJ, Berridge CW. Organization of hypocretin/orexin efferents to locus coeruleus and basal forebrain arousal-related structures. J Comp Neurol 2005; 481(2): 160-78.
105. Kocharyan A, Fernandes P, Tong XK, Vaucher E, Hamel E. Specific subtypes of cortical GABA interneurons contribute to the neurovascular coupling response to basal forebrain stimulation. J Cereb Blood Flow Metab 2008; 28(2): 221-31.
106. Dong HW, Heinbockel T, Hamilton KA, Hayar A, Ennis M. Metabotropic glutamate receptors and dendrodendritic synapses in the main olfactory bulb. Ann N Y Acad Sci 2009; 1170: 224-38.
107. Pan BX, Dong Y, Ito W, Yanagawa Y, Shigemoto R, Morozov A. Selective gating of glutamatergic inputs to excitatory neurons of amygdala by presynaptic GABAb receptor. Neuron 2009; 61(6): 917-29.
108. Liang CL, Marks GA. A novel GABAergic afferent input to the pontine reticular formation: the mesopontine GABAergic column. Brain Res 2009; 1297: 32-40.
109. Clauss RP. Neurotransmitters in coma, vegetative and minimally conscious states, pharmacological interventions. Med Hypotheses 2010; 75(3): 287-90.
110. Mtchedlishvili Z, Lepsveridze E, Xu H, Kharlamov EA, Lu B, Kelly KM. Increase of GABAA receptor-mediated tonic inhibition in dentate granule cells after traumatic brain injury. Neurobiol Dis 2010; 38(3): 464-75.
111. Porges SW. The polyvagal theory: new insights into adaptive reactions of the autonomic nervous system. Cleve Clin J Med 2009; 76(Suppl 2): S86-90.
112. Bateman RJ, Boychuk CR, Philbin KE, Mendelowitz D. β adrenergic receptor modulation of neurotransmission to cardiac vagal neurons in the nucleus ambiguus. Neuroscience 2012; 210: 58-66.
113. Berntson GG, Cacioppo JT, Grossman P. Whither vagal tone. Biol Psychol 2007; 74(2): 295-300.
114. Frank JG, Jameson HS, Gorini C, Mendelowitz D. Mapping and identification of GABAergic neurons in transgenic mice projecting to cardiac vagal neurons in the nucleus ambiguus using photouncaging. J Neurophysiol 2009; 101(4): 1755-60.
115. Davis SF, Derbenev AV, Williams KW, Glatzer NR, Smith BN. Excitatory and inhibitory local circuit input to the rat dorsal motor nucleus of the vagus originating from the nucleus tractus solitarius. Brain Res 2004; 1017(1-2): 208-17.
116. Krout KE, Mettenleiter TC, Karpitskiy V, Nguyen XV, Loewy AD. CNS neurons with links to both mood-related cortex and sympathetic nervous system. Brain Res 2005; 1050(1-2): 199-202.
117. Chan JY, Chan SH, Ong BT, Barnes CD. Anatomic and physiologic evaluation of a link between the nucleus reticularis gigantocellularis and nucleus ambiguous in the rat. Neurosci Lett 1986; 67(1): 31-6.
118. Cheng Z, Zhang H, Guo SZ, Wurster R, Gozal D. Differential control over postganglionic neurons in rat cardiac ganglia by NA and DmnX neurons: anatomical evidence. Am J Physiol Regul Integr Comp Physiol 2004; 286(4): R625-33.
119. Paschalis A, Churchill L, Marina N, Kasymov V, Gourine A, Ackland G. Beta1-Adrenoceptor distribution in the rat brain: an immunohistochemical study. Neurosci Lett. 2009; 458(2):84-8. doi: 10.1016/j.neulet.2009.04.023. Epub 2009 Apr 15.
120. Baguley IJ, Nott MT, Slewa-Younan S, Heriseanu RE, Perkes IE. Diagnosing dysautonomia after acute traumatic brain injury: evidence for overresponsiveness to afferent stimuli. Arch Phys Med Rehabil 2009; 90(4): 580-6.
121. Daquin G, Micallef J, Blin O. Yawning. Sleep Med Rev 2001; 5(4): 299-312.
122. BARBIZET J. Yawning. J Neurol Neurosurg Psychiatry 1958; 21(3): 203-9.
123. Wimalaratna HS, Capildeo R. Is yawning a brainstem phenomenon? Lancet 1988; 1(8580): 300.
124. Platek SM, Mohamed FB, Gallup GG, Jr. Contagious yawning and the brain. Brain Res Cogn Brain Res 2005; 23(2-3): 448-52.
125. Gallup AC. Why do we yawn? Primitive versus derived features. Neurosci Biobehav Rev 2011; 35(3): 765-9.
126. Guggisberg AG, Mathis J, Herrmann US, Hess CW. The functional relationship between yawning and vigilance. Behav Brain Res 2007; 179(1): 159-66.
127. Giganti F, Salzarulo P. Yawning throughout life. Front Neurol Neurosci 2010; 28: 26-31.
128. Tufik S, de Luca NC, Neumann B, et al. Effects of stress on druginduced yawning: constant vs. intermittent stress. Physiol Behav 1995; 58(1): 181-4.
129. Weinberg WA, Brumback RA. Primary disorder of vigilance: a novel explanation of inattentiveness, daydreaming, boredom, restlessness, and sleepiness. J Pediatr 1990; 116(5): 720-5.
130. Walusinski O, Deputte BL. [Yawn: from ethology to clinical medicine]. Rev Prat 2002; 52(18): 1981-3.
131. Walusinski O, Deputte BL. [The phylogeny, ethology and nosology of yawning]. Rev Neurol (Paris) 2004; 160(11): 1011-21.
132. Cattaneo L, Cucurachi L, Chierici E, Pavesi G. Pathological yawning as a presenting symptom of brain stem ischaemia in two patients. J Neurol Neurosurg Psychiatry 2006; 77(1): 98-100.
133. Argiolas A, Melis MR. The neuropharmacology of yawning. Eur J Pharmacol 1998; 343(1): 1-16.
134. Kasuya Y, Murakami T, Oshima T, Dohi S. Does yawning represent a transient arousal-shift during intravenous induction of general anesthesia? Anesth Analg 2005;101(2): 382-4.
135. Kim DW, Kil HY, White PF. Relationship between clinical endpoints for induction of anesthesia and bispectral index and effect-site concentration values. J Clin Anesth 2002; 14(4): 241-5.
136. Collins GT, Eguibar JR. Neurophamacology of yawning. Front Neurol Neurosci 2010; 28: 90-106.
137. Tsou CH, Kao T, Fan KT, Wang JH, Luk HN, Koenig HM. Clinical assessment of propofol-induced yawning with heart rate variability: a pilot study. J Clin Anesth 2008; 20(1): 25-9.
138. Tegeler ML, Baumrucker SJ. Gabapentin for intractable hiccups in palliative care. Am J Hosp Palliat Care 2008; 25(1): 52-4.
139. Becker DE. Nausea, vomiting, and hiccups: a review of mechanisms and treatment. Anesth Prog 2010; 57(4): 150-6.
140. Oshima T, Dohi S. Isoflurane facilitates hiccup-like reflex through gamma aminobutyric acid (GABA)A-and suppresses through GABAB-receptors in pentobarbital-anesthetized cats. Anesth Analg 2004; 98(2): 346-52.
141. McCann CC, Quera-Salva MA, Boudet J, Frisk M, Barthouil P, Borderies P, Meyer P. Effect of zolpidem during sleep on ventilation and cardiovascular variables in normal subjects. Fundam Clin Pharmacol 1993; 7(6): 305-10.
142. Shi SJ, Garcia KM, Meck JV. Temazepam, but not zolpidem, causes orthostatic hypotension in astronauts after spaceflight. J Cardiovasc Pharmacol 2003; 41(1): 31-9.
143. Cashman JN, Power SJ, Jones RM. Assessment of a new hypnotic imidazopyridine (zolpidem) as oral premedication. Br J Clin Pharmacol 1987; 24(1): 85-92.
144. Langtry HD, Benfield P. Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1990; 40(2): 291-313.
145. Garnier R, Guerault E, Muzard D, Azoyan P, Chaumet-Riffaud AE, Efthymiou ML. Acute zolpidem poisoning-analysis of 344 cases. J Toxicol Clin Toxicol 1994; 32(4): 391-404.
146. Kuzniar TJ, Balagani R, Radigan KA, Factor P, Mutlu GM. Coma with absent brainstem reflexes resulting from zolpidem overdose. Am J Ther 2010; 17(5): e172-4.
147. Mailliet F, Galloux P, Poisson D. Comparative effects of melatonin, zolpidem and diazepam on sleep, body temperature, blood pressure and heart rate measured by radiotelemetry in Wistar rats. Psychopharmacology (Berl) 2001; 156(4): 417-26.
148. Castro JL, Bogliuk C, Ramirez A. "Pharmacological caracterization of the cardiovascular effects of Zolpidem". AJH 1998;11.
149. Chen HY, Kuo TB, Shaw FZ, Lai CJ, Yang CC. Sleep-related vagotonic effect of zolpidem in rats. Psychopharmacology (Berl) 2005; 181(2): 270-9.
150. Alboni P, Alboni M, Gianfranchi L. Simultaneous occurrence of two independent vagal reflexes: a possible cause of vagal sudden death. Heart 2011; 97(8): 623-5.
151. Hull SS, Jr., Vanoli E, Adamson PB, De Ferrari GM, Foreman RD, Schwartz PJ. Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine. Circulation 1995; 91(10): 2516-9.
152. Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS, Jr., Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 1991; 68(5): 1471-81.